Literature DB >> 26302815

Systematically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation.

N K Yadav1, Sanju Nanda1, Gajanand Sharma2,3, O P Katare2.   

Abstract

Environmental stress and advancing age is considered as the main cause of skin aging. However, environmental stress (especially UV radiations) accelerates the process of skin aging by manifolds. Coenzyme Q10 (CoQ10), an essential compound of cellular bioenergetics also acts as a strong antioxidant and protects the body against aging. High molecular weight and structure specific lipophilic nature of this molecule is a bottle neck in effective delivery through topical route. Preparation of a novel proniosomal (PN) gel formulation of CoQ10 employing systematic design of experiment (DoE) approach is a step ahead in transcending the constraints of the topical delivery. I-optimal mixture design was employed for systematic optimization of proniosomal formulation and evaluation of experimental data was performed for entrapment efficiency and in vitro release. Hydration of PN gel formulation with phosphate buffer (pH 7.5) results in submicron niosomes vesicles of spherical shape, which appeared dark against bright surroundings in TEM study. Animal skin was treated with UV radiations followed by treatment of PN gel CoQ10 and conventional CoQ10 present in a gel base. The effectiveness of the treatment was evaluated on the basis of biochemical estimation and histopathological studies. By using CoQ10 PN gel formulation, levels of superoxide dismutase (SOD), catalase (CA), glutathione (GSH) and total proteins were restored by 81.3%, 72.1%, 74.8 and 77.1%, respectively to that of control group. Histopathological studies revealed better protection of skin treated with CoQ10 PN gel compared to free CoQ10. Prepared PN gel was found undisturbing with the normal histology hence, tolerated by animal skin compare to conventional gel.

Entities:  

Keywords:  Aging; CoQ10; I-optimal mixture design; biochemical estimation; proniosomes; sub-micron niosomes

Mesh:

Substances:

Year:  2015        PMID: 26302815     DOI: 10.3109/1061186X.2015.1077845

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  6 in total

1.  Nano-engineered lipid-polymer hybrid nanoparticles of fusidic acid: an investigative study on dermatokinetics profile and MRSA-infected burn wound model.

Authors:  Kanika Thakur; Gajanand Sharma; Bhupinder Singh; Sanjay Chhibber; Om Prakash Katare
Journal:  Drug Deliv Transl Res       Date:  2019-08       Impact factor: 4.617

2.  Proniosome: A Promising Approach for Vesicular Drug Delivery.

Authors:  Marzina Ajrin; Fahmida Anjum
Journal:  Turk J Pharm Sci       Date:  2022-08-31

3.  Innovative coenzyme Q10-loaded nanoformulation as an adjunct approach for the management of moderate periodontitis: preparation, evaluation, and clinical study.

Authors:  Mohamed A Shaheen; Samah H Elmeadawy; Fagr B Bazeed; Mohamed M Anees; Noha M Saleh
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

4.  Pluronic F127-tailored lecithin organogel of acyclovir: preclinical evidence of antiviral activity using BALB/c murine model of cutaneous HSV-1 infection.

Authors:  Gajanand Sharma; Bimaldeep Kaur; Kanika Thakur; Akanksha Mahajan; Basant Amarji; Mini P Singh; Om Prakash Katare
Journal:  Drug Deliv Transl Res       Date:  2021-01-23       Impact factor: 4.617

5.  Ubidecarenone-Loaded Nanostructured Lipid Carrier (UB-NLC): Percutaneous Penetration and Protective Effects Against Hydrogen Peroxide-Induced Oxidative Stress on HaCaT Cells.

Authors:  Jianmin Wang; Huiyun Wang; Qiang Xia
Journal:  Int J Mol Sci       Date:  2018-06-25       Impact factor: 5.923

6.  Network pharmacology-based screening of the active ingredients and mechanisms of Huangqi against aging.

Authors:  Siyu Lan; Jie Duan; Nan Zeng; Bin Yu; Xuping Yang; Hong Ning; Yilan Huang; Youyi Rao
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.